Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Hemangioendothelioma, Epithelioid × 30 days × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 225 Neoplasms 216 Carcinoma, Non-Small-Cell Lung 202 Prostatic Neoplasms 137 Colorectal Neoplasms 125 Lung Neoplasms 113 Neoplasm Metastasis 111 Leukemia, Myeloid, Acute 95 Ovarian Neoplasms 94 Multiple Myeloma 92 Pancreatic Neoplasms 71 Recurrence 69 Squamous Cell Carcinoma of Head and Neck 65 Endometrial Neoplasms 61 Carcinoma, Hepatocellular 56 Stomach Neoplasms 55 Melanoma 54 Triple Negative Breast Neoplasms 51 Carcinoma, Renal Cell 51 Urinary Bladder Neoplasms 50 Brain Neoplasms 50 Leukemia, Lymphocytic, Chronic, B-Cell 48 Lymphoma, Non-Hodgkin 47 Hematologic Neoplasms 47 Small Cell Lung Carcinoma 46 Lymphoma, Large B-Cell, Diffuse 46 Precursor Cell Lymphoblastic Leukemia-Lymphoma 43 Head and Neck Neoplasms 43 Sarcoma 39 Glioblastoma 39

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06408441 2026-04-03

EHE

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Sarcoma, Hemangioendothelioma, Epithelioid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡